These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32055575)

  • 1. Digital therapeutics and clinical pharmacology.
    Chung JY
    Transl Clin Pharmacol; 2019 Mar; 27(1):6-11. PubMed ID: 32055575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical Pharmacology.
    Ribba B; Peck R; Hutchinson L; Bousnina I; Motti D
    Clin Pharmacol Ther; 2023 Sep; 114(3):578-590. PubMed ID: 37392464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive survey of the clinical trial Landscape on digital therapeutics.
    Yao H; Liao Z; Zhang X; Zhang X; Li M; You L; Liu Y
    Heliyon; 2024 Aug; 10(16):e36115. PubMed ID: 39224386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital Therapeutics in Hearing Healthcare: Evidence-Based Review.
    Kim N; Nakamura KA
    J Audiol Otol; 2024 Jul; 28(3):159-166. PubMed ID: 38973323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access and reimbursement pathways for digital health solutions and
    Mantovani A; Leopaldi C; Nighswander CM; Di Bidino R
    Front Med Technol; 2023; 5():1101476. PubMed ID: 36891483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate controls for digital therapeutic clinical trials: A narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content.
    Lutz J; Offidani E; Taraboanta L; Lakhan SE; Campellone TR
    Front Digit Health; 2022; 4():823977. PubMed ID: 36060538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining Diversity in Digital Therapeutics Clinical Trials: Descriptive Analysis.
    Adu-Brimpong J; Pugh J; Darko DA; Shieh L
    J Med Internet Res; 2023 Aug; 25():e37447. PubMed ID: 37531157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Revolution of Digital Therapeutics (DTx) in the Pharmaceutical Industry and Their Quality Impacts.
    Rajendran A; Kella A; Narayanasamy D
    Cureus; 2024 Aug; 16(8):e66792. PubMed ID: 39268306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing.
    Miao BY; Sushil M; Xu A; Wang M; Arneson D; Berkley E; Subash M; Vashisht R; Rudrapatna V; Butte AJ
    Lancet Digit Health; 2024 Mar; 6(3):e222-e229. PubMed ID: 38395542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the key drivers of the Japanese digital therapeutics patents: A cross-sectional study.
    Oda T; Oda C
    Health Sci Rep; 2023 Jun; 6(6):e1268. PubMed ID: 37275666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the potential of digital therapeutics: An assessment of progress and promise.
    Armeni P; Polat I; De Rossi LM; Diaferia L; Meregalli S; Gatti A
    Digit Health; 2024; 10():20552076241277441. PubMed ID: 39291152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Category and Use Cases on Digital Therapeutic Methodologies.
    An S; Ko J; Yu KS; Kwon H; Kim S; Hong J; Kong HJ
    Healthc Inform Res; 2023 Jul; 29(3):190-198. PubMed ID: 37591674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reimbursement of Digital Therapeutics: Future Perspectives in Korea.
    Ju JH; Sim B; Lee J; Lee JY
    Korean Circ J; 2022 Apr; 52(4):265-279. PubMed ID: 35388995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to Adoption of Digital Therapeutics (DTx) into Audiology Clinical Practice: Acknowledging the Challenges, Adapting to the Future.
    Roberts MJ; Wilson WJ; Recugnat M; Bardy F
    Semin Hear; 2023 Aug; 44(3):319-327. PubMed ID: 37484989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Evaluation of Digital Therapeutics: Present and Future.
    Huh KY; Oh J; Lee S; Yu KS
    Healthc Inform Res; 2022 Jul; 28(3):188-197. PubMed ID: 35982593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apprehensions about Excessive Belief in Digital Therapeutics: Points of Concern Excluding Merits.
    Kim HS
    J Korean Med Sci; 2020 Nov; 35(45):e373. PubMed ID: 33230984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription digital therapeutics: A new frontier for pharmacists and the future of treatment.
    Shafai G; Aungst TD
    J Am Pharm Assoc (2003); 2023; 63(4):1030-1034. PubMed ID: 37019379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethics of digital therapeutics (DTx).
    Refolo P; Sacchini D; Raimondi C; Spagnolo AG
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6418-6423. PubMed ID: 36196692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital therapeutics in neurology.
    Abbadessa G; Brigo F; Clerico M; De Mercanti S; Trojsi F; Tedeschi G; Bonavita S; Lavorgna L
    J Neurol; 2022 Mar; 269(3):1209-1224. PubMed ID: 34018047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription digital therapeutics: Applying Medicaid experience to value assessment and formulary management.
    Salsabili M; Tesell M; Alcusky M; Greenwood BC; Huang D; Lenz K; Dave J
    J Manag Care Spec Pharm; 2023 Jun; 29(6):685-691. PubMed ID: 37276040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.